Glucose metabolism in heart transplant recipients treated with FK506 or cyclosporine.
Sahar
G
G
Department of Cardiothoracic Surgery, Heart-Lung Transplant Unit, Rabin Medical Center, Beilinson Campus, Israel.
Berman
M
M
Ben-Gal
T
T
Sahar
E
E
Kogan
A
A
Michowitch
R
R
Saute
M
M
Kramer
M
M
Sagie
A
A
Shapira
Y
Y
Aravot
D
D
Vidne
B A
BA
D001786:Blood Glucose / Q000378:metabolism*; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use*; D005500:Follow-Up Studies; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000627:therapeutic use*; D016559:Tacrolimus / Q000097:blood / Q000627:therapeutic use*; D013997:Time Factors
D001786:Blood Glucose; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus